Charles River Laboratories Joins Exostar's Life Sciences Community

HERNDON, Va.--Exostar, whose cloud-based solutions enable secure, cost-effective business-to-business collaboration, today recognized Charles River Laboratories as the first clinical research organization (CRO) to join Exostar's rapidly growing Life Sciences community, which currently includes numerous CROs among the more than 500 organizations and 10,000 individuals in almost 50 countries worldwide. The Exostar Life Sciences Identity Hub brings CROs, pharmaceutical manufacturers, academic institutions, and others in the industry together in an environment that facilitates secure collaboration, reduces capital and operating expenditures, and drives revenue by enhancing productivity and speeding time-to-market.

Charles River provides essential products and services including basic research, discovery, safety and efficacy, clinical support, and process manufacturing. Leading pharmaceutical and biotechnology companies, government agencies, and academic institutions around the world count on Charles River to accelerate their research and drug development efforts.

Organizations need only connect once to the cloud-based Exostar Life Sciences Identity Hub, opening the door to external partner collaboration through portals, applications, and information sharing. Because the Exostar solution is delivered as-a-Service, organization and user provisioning can be standardized and streamlined, slashing the time to collaboration from weeks or months to days.

Exostar controls access to the community and its assets through its Secure Access Manager (SAM) service offering. SAM verifies identities of individuals and permits access based on authentication methods and permissions defined by asset owners. Charles River opted for SAM'sEnterprise Access Gateway (EAG) capability to more closely integrate with the community. With EAG, Charles River employees benefit from a true single sign-on experience, using their existing credentials to reach partner assets.

"Charles River's commitment to being a fully integrated partner with its customers makes our Life Sciences collaboration platform a perfect complement to its mission," said Vijay Takanti, Exostar's Vice President of Security and Collaboration Solutions. "Other CROs and industry partners are enhancing their value by following Charles River's lead and becoming part of our community."

About Exostar

Exostar powers secure business-to-business information sharing, collaboration and business process integration throughout the value chain. Exostar supports the complex trading needs of many of the world's largest companies in aerospace and defense, life sciences, and other industries. Exostar's cloud-based identity assurance products and business applications reduce risk, improve agility and strengthen trading partner relationships and profitability for over 100,000 companies in 150 countries worldwide. The Exostar community includes market leaders such as AstraZeneca, BAE Systems, Bell Helicopter, The Boeing Company, Computer Sciences Corporation, Lockheed Martin Corp., Merck, Newport News Shipbuilding, Northrop Grumman, Raytheon Co. and Rolls-Royce. For more information, please visit

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.